Po Yee Mak

1PUBLICATIONS
10CO-AUTHORS
Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jul 13, 2026
The novel hypomethylating agent NTX-301 reprograms epigenetic and Hippo signaling pathways and exhibits pre-clinical activity in venetoclax-resistant and TP53-mutant AML.

Pageof 1

Frequent Collaborators

1 joint publications

Bing Z Carter

1 joint publications

Suresh Satpati

1 joint publications

Edward Ayoub

1 joint publications

Steffen Boettcher